THE BACKED BY YEARS OF RESEARCH AND A TEAM OF TOP-NOTCH EXPERTS DIARIES

Under each Drake’s and Lynch’s styles, the cost of deleterious mutations is exactly what drives mutation premiums down (Drake 1991; Lynch 2010; Sung et al. 2012). as a result, under the two models, an increase in the normal expense of mutations would lead to a reduce in mutation premiums. To examine this, Drake examined mutation costs of thermo